HIV and Hepatitis C Among People Who Inject Drugs in Memphis, Tennessee: an Intersectional Risk Environment Analysis of the Social Determinants of Health

被引:0
|
作者
Flath, Natalie [1 ]
Marr, Jack H. [2 ]
Sizemore, Lindsey [3 ]
Pichon, Latrice C. [4 ]
Brantley, Meredith [5 ]
机构
[1] Johns Hopkins Bloomberg, Sch Publ Hlth, Dept Mental Hlth, 624 N Broadway, Baltimore, MD 21205 USA
[2] Tennessee Dept Hlth, Communicable & Environm Dis & Emergency Preparedn, 710 James Robertson Pkwy,4th Floor, Nashville, TN 37243 USA
[3] Tennessee Dept Hlth, 710 James Robertson Pkwy,4th Floor, Nashville, TN 37243 USA
[4] Univ Memphis, Sch Publ Hlth, Div Social & Behav Sci, 209 Robison Hall, Memphis, TN 38152 USA
[5] Tennessee Dept Hlth, 710 James Robertson Pkwy,4th Floor, Nashville, TN 37243 USA
关键词
HIV; HCV; Persons who inject drugs; Social determinants of health; Intersectional public health; OPIOID CRISIS; UNITED-STATES; B-VIRUS; BALTIMORE; INFECTION; VULNERABILITY; POPULATIONS; DISPARITIES; IMPACT; AIDS;
D O I
10.1007/s40615-023-01878-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundThe Southern US is confronting bourgeoning HIV and hepatitis C virus (HCV) epidemics among people who inject drugs (PWID), yet little is known about shared and unique risk factors across the region. We applied an intersectional risk environment framework to understand infectious disease outcomes for sub-groups of PWID that experience multiple axes of social marginalization related to racial and ethnic identity and social and economic vulnerability.MethodsHIV and HCV prevalence was estimated from the first iteration of the CDC's National HIV Behavioral Surveillance respondent driven sample of PWID in Shelby County, Tennessee in 2018. We ran adjusted multinomial models to test main and interaction effects of race/ethnicity and structural factors on the prevalence of a three-level outcome: HIV-only, HCV-only, and no infection.ResultsA total of 564 PWID participated, 558 (99%) completed HIV testing, and 540 (96%) HCV testing. Thirty (5%) were HIV-positive, 224 (40%) HCV-positive, and less than 1% were co-infected. Descriptive differences by race/ethnicity and levels of structural vulnerability for HIV and HCV subpopulations were present; however, there was no evidence for statistical interaction. In the final main effects model, HIV status was positively associated with non-Hispanic Black identity (aRR 4.95, 95% CI 1.19, 20.6), whereas HCV status was associated with non-white identity (aRR 0.11 95% CI 0.07, 0.18). Factors associated with HCV infection were higher scores of structural vulnerability (aRR 2.19 95% CI 1.10, 4.35), and criminal legal involvement (aOR 1.99 95% CI 1.18, 3.37).ConclusionThis is the first study to implement local population-based survey data to evaluate distinctive intersections of ethnic/racial and social factors associated with HIV and HCV status among PWID in the Memphis region. Findings come at an opportune time as harm reduction programs are in development in the South and shed light to the need for socially equitable race conscious resource investment.
引用
收藏
页码:361 / 373
页数:13
相关论文
共 50 条
  • [1] An Analysis of Social Determinants of Health and Their Implications for Hepatitis C Virus Treatment in People Who Inject Drugs: The Case of Baltimore
    Gonzalez Corro, Luis A.
    Zook, Katie
    Landry, Miles
    Rosecrans, Amanda
    Harris, Robert
    Gaskin, Darrell
    Falade-Nwulia, Oluwaseun
    Page, Kathleen R.
    Lucas, Gregory M.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (04):
  • [2] Hepatitis C virus risk among young people who inject drugs
    Mateu-Gelabert, Pedro
    Sabounchi, Nasim S.
    Guarino, Honoria
    Ciervo, Courtney
    Joseph, Kellie
    Eckhardt, Benjamin J.
    Fong, Chunki
    Kapadia, Shashi N.
    Huang, Terry T. K.
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [3] History of detention and the risk of hepatitis C among people who inject drugs in Germany
    Gassowski, Martyna
    Nielsen, Stine
    Bannert, Norbert
    Bock, Claus-Thomas
    Bremer, Viviane
    Ross, R. Stefan
    Wenz, Benjamin
    Marcus, Ulrich
    Zimmermann, Ruth
    Hecht, Andreas
    Heinz, Werner
    Klee, Juergen
    Leicht, Astrid
    Scherbaum, Norbert
    Schaeffer, Dirk
    Santos-Hoevener, Claudia
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 81 : 100 - 106
  • [4] Transmission Patterns of HIV and Hepatitis C Virus among Networks of People Who Inject Drugs
    Pilon, Richard
    Leonard, Lynne
    Kim, John
    Vallee, Dominic
    De Rubeis, Emily
    Jolly, Ann M.
    Wylie, John
    Pelude, Linda
    Sandstrom, Paul
    PLOS ONE, 2011, 6 (07):
  • [5] Prevalence of hepatitis B and C, HIV, and syphilis among people who inject drugs in Germany
    Steffen, G.
    Krings, A.
    Zimmermann, R.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022, 32
  • [6] Hepatitis C Virus Vaccines Among People Who Inject Drugs
    Cox, Andrea L.
    Thomas, David L.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 : S46 - S50
  • [7] Hepatitis C prevalence among people who inject drugs in Hungary
    Gyarmathy, V. Anna
    Sarosi, Peter
    LANCET INFECTIOUS DISEASES, 2015, 15 (11): : 1261 - 1262
  • [8] Hepatitis C virus prevalence, determinants, and cascade of care among people who inject drugs in Iran
    Khezri, Mehrdad
    Mirzazadeh, Ali
    Shokoohi, Mostafa
    Sharafi, Heidar
    Ghalekhani, Nima
    Tavakoli, Fatemeh
    Mehmandoost, Soheil
    Mousavian, Ghazal
    Imani, Mousa
    Kakavand-Ghalehnoei, Rezvan
    Komasi, Ali
    Gouya, Mohammad Mehdi
    Haghdoost, Ali Akbar
    McFarland, Willi
    Karamouzian, Mohammad
    Sharifi, Hamid
    DRUG AND ALCOHOL DEPENDENCE, 2023, 243
  • [9] Public health interventions for reducing HIV, hepatitis B and hepatitis C infections in people who inject drugs
    Richardson, D.
    Bell, C.
    PUBLIC HEALTH ACTION, 2018, 8 (04): : 153 - 153
  • [10] Individual Heterogeneity and Trends in Hepatitis C Infection Risk Among People Who Inject Drugs: A Longitudinal Analysis
    Grantz, Kyra H.
    Cepeda, Javier
    Astemborski, Jacqueline
    Kirk, Gregory D.
    Thomas, David L.
    Mehta, Shruti H.
    Wesolowski, Amy
    JOURNAL OF VIRAL HEPATITIS, 2025, 32 (04)